An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
ABSTRACT Influenza, as well as other respiratory viruses, can trigger local and systemic inflammation resulting in an overall “cytokine storm” that produces serious outcomes such as acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). We hypothesized that gene therapy platforms cou...
Saved in:
Main Authors: | Kari Ann Shirey, John Joseph, Lynda Coughlan, Haye Nijhuis, Alan W. Varley, Jorge C. G. Blanco, Stefanie N. Vogel |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2025-02-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03387-24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model
by: Sang-A. Oh, et al.
Published: (2025-02-01) -
HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats
by: Rathasapa Patarat, et al.
Published: (2025-01-01) -
The role of Box A of HMGB1 in producing γH2AX associated DNA breaks in lung cancer
by: Sirapat Settayanon, et al.
Published: (2025-01-01) -
ROS anchor PAMPs-mediated extracellular HMGB1 self-association and its dimerization enhances pro-inflammatory signaling
by: Man Sup Kwak, et al.
Published: (2025-03-01) -
Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers
by: Xin Wang, et al.
Published: (2025-02-01)